W
Welcure Drugs and Pharmaceuticals Ltd
BSE:524661
Welcure Drugs and Pharmaceuticals Ltd
BSE:524661
Price:
0.25
INR
Market Cap:
₹309m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
W
|
Welcure Drugs and Pharmaceuticals Ltd
BSE:524661
|
IN |
|
G
|
Guangdong Yueyun Transportation Co Ltd
HKEX:3399
|
CN |
|
G
|
GR Properties Ltd
HKEX:108
|
HK |
|
Glory Ltd
TSE:6457
|
JP |
|
B
|
Bonlon Industries Ltd
BSE:543211
|
IN |
|
Playmates Toys Ltd
HKEX:869
|
HK |
|
Anupam Rasayan India Ltd
NSE:ANURAS
|
IN |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
|
Zhiyang Innovation Technology Co Ltd
SSE:688191
|
CN |
|
S
|
SolidusGold Inc
XTSX:SDC
|
CA |
|
A
|
Al Mawarid Manpower Company SCJSC
SAU:1833
|
SA |
|
I
|
Investeko SA
WSE:IVE
|
PL |
|
China Zenith Chemical Group Ltd
HKEX:362
|
HK |
|
R
|
Resintech Bhd
KLSE:RESINTC
|
MY |
|
G
|
GV Films Ltd
BSE:523277
|
IN |
|
Ituran Location and Control Ltd
NASDAQ:ITRN
|
IL |
|
Wellness and Beauty Solutions Ltd
ASX:WNB
|
AU |
|
Turk Telekomunikasyon AS
IST:TTKOM.E
|
TR |
Relative Value
The Relative Value of one WELCURE stock under the Base Case scenario is hidden INR. Compared to the current market price of 0.25 INR, Welcure Drugs and Pharmaceuticals Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
WELCURE Relative Value
HIDDEN
Multiples Across Competitors
WELCURE Competitors Multiples
Welcure Drugs and Pharmaceuticals Ltd Competitors
Welcure Drugs and Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
W
|
Welcure Drugs and Pharmaceuticals Ltd
BSE:524661
|
309.4m INR | 0.1 | 0.9 | 3.6 | 3.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.4 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
